Skip to main content

Advertisement

Table 1 Metabolic risk health service evaluation framework

From: Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service

Process Indicators [17, 22, 23] Outcome Indicators [17, 18] Quality Indicators [20, 21, 24]
• Patient initiation with the metabolic clinic i.e. through the government mental health service
• Enrolment process
• Case load, i.e. how many patients can be managed, workload implications, time per consultation
• Management of patients’ issues at the lowest appropriate level (i.e. lowest primary health care level and minimum level of service)
• Service components provided by nurse practitioner vs pharmacist vs pharmacy assistant
• Process involved in outcomes reporting [17]
• Referrals and associated communication [23]
• Follow-up of the patient [23]
• Consultation fee (eligibility for funded services vs fee-for service)
• Data recorded at different points of consultation [22]
• Baseline data collection [22]
• Mode of documentation [23]
• Monitoring of patient improvement and evaluation of progression [21]
• Qualitative data (free-text notes, reflections) [18]
• Patient compliance with medication, relative to adverse effects experienced, pill counting and dispensing or supply intervals [18]
• Improvement in overall health status of patient (physical and mental health)
• Data collected (e.g. biometric parameters, subjective assessments, patients’ concerns) [17]
• Review of the data/readings obtained [18]
• Patient privacy and confidentiality [21]
• Treatment plan customisation for each patient [20]
• Level of patient assessment. Is it only based on improving physical symptoms (confirmed by lab tests), or does it also include psychological and emotional improvement? [20, 24]
• Patient education regarding their condition, treatment and medication side effects [20]
• Simplicity of information (verbal and written) provided to patients (review sources of information) [20]
• Up-to-date record keeping [20]
• Level of pharmacists’ communication with other health professionals [20, 21]
• Staff understanding that mental health patients may feel stigmatised and hence treat patients in an understanding manner (staff completing training specific to mental health) [20]
• Pharmacist involvement in professional development courses to enhance knowledge in providing the disease state management service [21]
• Promotional activities undertaken in relation to mental health, as a form of encouragement for current patients [20]
• Improvements in the metabolic clinic service